Markets
NVS

Health Care Sector Update for 02/12/2016: GSK, NVS

Top Health-care stocks:

JNJ: +0.3%

PFE: +0.9%

ABT: flat

MRK: flat

AMGN: +0.4%

Health-care shares were mainly higher in pre-market trade Friday.

In health-care stocks news, GlaxoSmithKline ( GSK ) is among the companies fined by the UK's Competition & Markets Authority for anti-competitive conduct in relation to the supply of paroxetine, according to a release from the regulatory agency.

Shares in the company were 0.1% lower at $39.11 pre-bell. The company has traded between $37.24 and $49.08 over the past 52 weeks.

And Novartis AG ( NVS ), a developer, manufacturer and marketer of healthcare products led by pharmaceuticals, said Friday that its generic pharmaceuticals division, Sandoz, has acquired from Pfizer ( PFE ) the rights for the development and commercialization of PF-06438179 (biosimilar infliximab) in the 28 countries that form the European Economic Area.

Shares in the company were 0.4% higher at $72.46 pre-bell. The company has traded between $71.55 and $106.84 over the past 52 weeks.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Copyright (C) 2016 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.


The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story

NVS GSK PFE

Other Topics

Commodities

Latest Markets Videos